- Home
- SLNG vs IMA Comparison
SLNG vs IMA Comparison
Compare SLNG & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SLNG | IMA |
|---|---|---|
| Founded | 2013 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.0M | 92.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SLNG | IMA |
|---|---|---|
| Price | $5.08 | $6.20 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 2 |
| Target Price | $10.00 | ★ $16.00 |
| AVG Volume (30 Days) | 5.6K | ★ 63.8K |
| Earning Date | 11-05-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $72,270,000.00 | $800,000.00 |
| Revenue This Year | $7.02 | N/A |
| Revenue Next Year | $7.68 | N/A |
| P/E Ratio | $93.78 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.29 | $6.19 |
| 52 Week High | $8.28 | $18.00 |
Technical Indicators
Market Signals| Indicator | SLNG | IMA |
|---|---|---|
| Relative Strength Index (RSI) | 62.76 | N/A |
| Support Level | $4.92 | N/A |
| Resistance Level | $5.17 | N/A |
| Average True Range (ATR) | 0.15 | 0.00 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 96.97 | 0.00 |
Price Performance
Historical ComparisonAbout SLNG Stabilis Solutions Inc.
Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. It has a geographical presence in the United States and Mexico.
About IMA ImageneBio Inc.
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.